Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?

We recently published a list of 15 Cheapest Stocks Insiders Are Buying In March. In this article, we are going to take a look at where Alzamend Neuro, Inc. (NASDAQ:ALZN) stands against other cheapest stocks insiders are buying in March.

After solid gains Monday, the broader market index and blue chip companies traded flat Tuesday, while the NASDAQ Composite rose 0.2%. Monday’s enthusiasm came from hopes of looser U.S. tariffs.

Investors mostly ignored the March consumer confidence data released on Tuesday, which showed a sharp decline in U.S. consumers’ short-term outlook on income, business, and job conditions, reports CNBC.

“Sentiment continues to wane among investors, consumers and businesses as economic concerns and economic policy uncertainty takes its toll,” said Bret Kenwell, U.S. investment analyst at eToro. “Until there’s more certainty on the tariff and macro front, sentiment and confidence remain vulnerable.”

As investors navigate daily market changes, uncertainty remains a persistent factor. Insider trading tends to attract attention during these periods, as purchases of company stock by executives may suggest optimism about the company’s future. However, insider selling doesn’t necessarily signal a lack of confidence—it could simply be for personal financial reasons or to diversify holdings. Many executives use pre-established plans, such as 10b5-1, to maintain transparency. While insider trading can provide useful insights, it’s important to evaluate it alongside a company’s financial stability, broader market trends, and industry dynamics.

What are some of the cheapest stocks insiders have been buying this month so far? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least two insiders had purchased shares in March. From there, we ranked the 10 stocks with the lowest average price per share.

Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

With each stock, we note the average price per share of these purchases and the stock’s market capitalization.

Alzamend Neuro, Inc. (NASDAQ:ALZN)

Market Capitalization: $6.73 million

Alzamend Neuro, a clinical-stage biopharmaceutical company, ranks 10^th among the 15 cheapest stocks insiders are buying this month. The Atlanta, Georgia-headquartered company focuses on developing treatments for neurodegenerative and psychiatric disorders. Its pipeline includes AL001, a combination therapy for Alzheimer’s and other mental health conditions, and ALZN002, a cell-based therapeutic vaccine for Alzheimer’s. The company partners with Massachusetts General Hospital for AL001’s Phase II clinical trial.

The company recently announced plans to begin a Phase II clinical study of AL001 for the treatment of patients with Major Depressive Disorder (MDD) in the fourth quarter of 2025. This follows the successful completion of a head coil by Tesla Dynamic Coils BV, a crucial component for the trial. In partnership with Massachusetts General Hospital as its contract research organization, Alzamend aims to investigate the unique properties of AL001 and its effects on lithium delivery in the brain compared to existing lithium salts.

This month, two insiders, including the CFO, purchased around $14,621 worth of Alzamend Neuro shares at an average price of $0.90 per share. Since the beginning of the year, Alzamend shares have declined 12.07%, trading at $1.02. Over the past 12 months, Alzamend lost 89.90%.

StockAnalysis reports that one analyst has rated Alzamend Neuro stock as a “Strong Buy” with a price target of $20.00.

Overall, ALZN ranks 10th on our list of cheapest stocks insiders are buying in March. While we acknowledge the potential of ALZN our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ALZN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.